Abstract
BackgroundLevosimendan is a positive inotropic drug that was approved in our country for the short term treatment of acute decompensation in chronic heart failure in situations where conventional treatment is...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
